Trevena Inc (NAS:TRVN)
$ 6.7 -0.79 (-10.55%) Market Cap: 5.71 Mil Enterprise Value: 26.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q4 2020 Trevena Inc Earnings Call Transcript

Mar 09, 2021 / 01:00PM GMT
Release Date Price: $1281.25
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Trevena Fourth Quarter and Full Year 2020 Financial Results Conference Call.

I'd now like to hand the conference over to your host today, Mr. Barry Shin, Senior Vice President and Chief Financial Officer.

Barry Shin
Trevena, Inc. - Senior VP & CFO

Good morning, and welcome, everyone. With me today from Trevena are Carrie Bourdow, our President and CEO; Bob Yoder, our Chief Commercial Officer; and our Chief Medical Officer, Mark Demitrack. We also have Dr. Greg Hammer from Stanford University Medical Center with us. Dr. Hammer was an investigator in our Phase III open-label safety study. He'll be sharing his firsthand experience with OLINVYK. At the end of the call, we'll open it up for questions.

As a reminder, we'll be making forward-looking statements within the meaning of federal securities law. These statements are subject to risks and uncertainties related to our business, including those covered in our filings with the SEC. We undertake no obligation to update

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot